|
1
|
Kreike B, van Kouwenhove M, Horlings H, et
al: Gene expression profiling and histopathological
characterization of triple-negative/basal-like breast carcinomas.
Breast Cancer Res. 9:R652007. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rakha EA, Reis-Filho JS and Ellis IO:
Basal-like breast cancer: a critical review. J Clin Oncol.
26:2568–2581. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Carey LA, Perou CM, Livasy CA, et al:
Race, breast cancer subtypes, and survival in the Carolina Breast
Cancer Study. JAMA. 295:2492–2502. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Huarte M and Rinn JL: Large non-coding
RNAs: missing links in cancer? Hum Mol Genet. 19:R152–R161. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Spizzo R, Almeida MI, Colombatti A and
Calin GA: Long non-coding RNAs and cancer: a new frontier of
translational research? Oncogene. 31:4577–4587. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tsai MC, Spitale RC and Chang HY: Long
intergenic noncoding RNAs: new links in cancer progression. Cancer
Res. 71:3–7. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Okazaki Y, Furuno M, Kasukawa T, et al:
Analysis of the mouse transcriptome based on functional annotation
of 60,770 full-length cDNAs. Nature. 420:563–573. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Guttman M, Amit I, Garber M, et al:
Chromatin signature reveals over a thousand highly conserved large
non-coding RNAs in mammals. Nature. 458:223–227. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Perez DS, Hoage TR, Pritchett JR, et al:
Long, abundantly expressed non-coding transcripts are altered in
cancer. Hum Mol Genet. 17:642–655. 2008. View Article : Google Scholar
|
|
10
|
Han L, Zhang K, Shi Z, et al: LncRNA
profile of glioblastoma reveals the potential role of lncRNAs in
contributing to glioblastoma pathogenesis. Int J Oncol.
40:2004–2012. 2012.PubMed/NCBI
|
|
11
|
Myatt SS and Lam EW: The emerging roles of
forkhead box (Fox) proteins in cancer. Nat Rev Cancer. 7:847–859.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xia L, Huang W, Tian D, et al:
Overexpression of forkhead box C1 promotes tumor metastasis and
indicates poor prognosis in hepatocellular carcinoma. Hepatology.
57:610–624. 2013. View Article : Google Scholar
|
|
13
|
Xu ZY, Ding SM, Zhou L, et al: FOXC1
contributes to microvascular invasion in primary hepatocellular
carcinoma via regulating epithelial-mesenchymal transition. Int J
Biol Sci. 8:1130–1141. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sizemore ST and Keri RA: The forkhead box
transcription factor FOXC1 promotes breast cancer invasion by
inducing matrix metalloprotease 7 (MMP7) expression. J Biol Chem.
287:24631–24640. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ray PS, Wang J, Qu Y, et al: FOXC1 is a
potential prognostic biomarker with functional significance in
basal-like breast cancer. Cancer Res. 70:3870–3876. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ray PS, Bagaria SP, Wang J, et al:
Basal-like breast cancer defined by FOXC1 expression offers
superior prognostic value: a retrospective immunohistochemical
study. Ann Surg Oncol. 18:3839–3847. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang L, Gu F, Liu CY, Wang RJ, Li J and Xu
JY: High level of FOXC1 expression is associated with poor
prognosis in pancreatic ductal adenocarcinoma. Tumour Biol.
34:853–858. 2013. View Article : Google Scholar
|
|
18
|
Wei LX, Zhou RS, Xu HF, Wang JY and Yuan
MH: High expression of FOXC1 is associated with poor clinical
outcome in non-small cell lung cancer patients. Tumour Biol.
34:941–946. 2013. View Article : Google Scholar
|
|
19
|
Livasy CA, Karaca G, Nanda R, et al:
Phenotypic evaluation of the basal-like subtype of invasive breast
carcinoma. Mod Pathol. 19:264–271. 2006. View Article : Google Scholar
|
|
20
|
Nielsen TO, Hsu FD, Jensen K, et al:
Immunohistochemical and clinical characterization of the basal-like
subtype of invasive breast carcinoma. Clin Cancer Res.
10:5367–5374. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gupta RA, Shah N, Wang KC, et al: Long
non-coding RNA HOTAIR reprograms chromatin state to promote cancer
metastasis. Nature. 464:1071–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Iacoangeli A, Lin Y, Morley EJ, et al:
BC200 RNA in invasive and preinvasive breast cancer.
Carcinogenesis. 25:2125–2133. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Redis RS, Sieuwerts AM, Look MP, et al:
CCAT2, a novel long non-coding RNA in breast cancer: expression
study and clinical correlations. Oncotarget. 4:1748–1762.
2013.PubMed/NCBI
|
|
24
|
Shtivelman E and Bishop JM: Effects of
translocations on transcription from PVT. Mol Cell Biol.
10:1835–1839. 1990.PubMed/NCBI
|
|
25
|
Guan Y, Kuo WL, Stilwell JL, et al:
Amplification of PVT1 contributes to the pathophysiology of ovarian
and breast cancer. Clin Cancer Res. 13:5745–5755. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Preker P, Nielsen J, Kammler S, et al: RNA
exosome depletion reveals transcription upstream of active human
promoters. Science. 322:1851–1854. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jacquier A: The complex eukaryotic
transcriptome: unexpected pervasive transcription and novel small
RNAs. Nat Rev Genet. 10:833–844. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Preker P, Almvig K, Christensen MS, et al:
PROMoter uPstream Transcripts share characteristics with mRNAs and
are produced upstream of all three major types of mammalian
promoters. Nucleic Acids Res. 39:7179–7193. 2011. View Article : Google Scholar : PubMed/NCBI
|
